
    
      This study is being conducted under the Sponsorship of the University of Alberta (Edmonton,
      Alberta, Canada) and is funded by Canadian Institutes of Health Industry Partnered Research
      Grant IRO 90262 - with partnership funding from Abbott Laboratories. The co-Principal
      Investigators are Marcello Tonelli MD SM and Ravi Thadhani, MD, MPH . A total of 750 patients
      are anticipated being enrolled at Massachusetts General Hospital (MGH). The remaining
      patients are being enrolled in Canada.

      This study will utilize data from "The Canadian Kidney Disease Cohort Study" (CKDCS) and "The
      Longitudinal US/Canada Incident Dialysis STUDY (LUCID).
    
  